These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 312482)

  • 1. Dihydropteridine reductase deficiency associated with severe neurologic disease and mild hyperphenylalaninemia.
    Brewster TG; Moskowitz MA; Kaufman S; Breslow JL; Milstien S; Abroms IF
    Pediatrics; 1979 Jan; 63(1):94-9. PubMed ID: 312482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A disorder of biogenic amines in dihydropteridine reductase deficiency.
    Butler IJ; Koslow SH; Krumholz A; Holtzman NA; Kaufman S
    Ann Neurol; 1978 Mar; 3(3):224-30. PubMed ID: 27135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hyperphenylalaninaemia with normal phenylalanine-hydroxylase activity and a deficiency of tetrahydrobiopterin and dihydropteridine reductase].
    Rey F; Harpey JP; Leeming RJ; Blair JA; Aicardi J; Rey J
    Arch Fr Pediatr; 1977; 34(7 Suppl):CIX-CXX. PubMed ID: 931522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atypical phenylketonuria with normal phenylalanine hydroxylase and dihydropteridine reductase activity in vitro.
    Bartholomé K; Byrd DJ; Kaufman S; Milstien S
    Pediatrics; 1977 May; 59(5):757-61. PubMed ID: 300866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biogenic amine synthesis defect in dihydropteridine reductase deficiency.
    Koslow SH; Butler IJ
    Science; 1977 Nov; 198(4316):522-3. PubMed ID: 20665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperphenylalaninemia due to dihydropteridine reductase deficiency: diagnosis by measurement of oxidized and reduced pterins in urine.
    Milstien S; Kaufman S; Summer GK
    Pediatrics; 1980 Apr; 65(4):806-10. PubMed ID: 7367090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenylketonuria due to a deficiency of dihydropteridine reductase.
    Kaufman S; Holtzman NA; Milstien S; Butler LJ; Krumholz A
    N Engl J Med; 1975 Oct; 293(16):785-90. PubMed ID: 1160969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperphenylalaninemia due to dihydropteridine reductase deficiency: diagnosis by enzyme assays on dried blood spots.
    Arai N; Narisawa K; Hayakawa H; Tada K
    Pediatrics; 1982 Sep; 70(3):426-30. PubMed ID: 7110817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 6-pyruvoyl-tetrahydropterin synthase deficiency with mild hyperphenylalaninemia.
    Demos MK; Waters PJ; Vallance HD; Lillquist Y; Makhseed N; Hyland K; Blau N; Connolly MB
    Ann Neurol; 2005 Jul; 58(1):164-7. PubMed ID: 15984017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Malignant phenylketonuria due to defective synthesis of dihydrobiopterin.
    Cohen BE; Szeinberg A; Quint J; Normand M; Blonder J; Peled I
    Isr J Med Sci; 1985 Jun; 21(6):520-5. PubMed ID: 3874852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenylketonuria and its variants.
    Kaufman S; Milstien S
    Ann Clin Lab Sci; 1977; 7(2):178-85. PubMed ID: 557947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperphenylalaninemia due to a deficiency of biopterin. A variant form of phenylketonuria.
    Kaufman S; Berlow S; Summer GK; Milstien S; Schulman JD; Orloff S; Spielberg S; Pueschel S
    N Engl J Med; 1978 Sep; 299(13):673-9. PubMed ID: 683251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparative effects of different inhibitors of phenylalanine hydroxylase and dihydropteridine reductase. In vivo and in vitro study in rats].
    Charpentier C; Domange C; Wolf M; Barthon F; Laggoune B; Lemonnier A
    Arch Fr Pediatr; 1978 Dec; 35(10 Suppl):93-101. PubMed ID: 571268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperphenylalaninaemia due to dihydropteridine reductase deficiency.
    Gröbe H; Bartholome K; Milstien S; Kaufman S
    Eur J Pediatr; 1978 Sep; 129(2):93-8. PubMed ID: 28230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biopterin synthesis defect. Treatment with L-dopa and 5-hydroxytryptophan compared with therapy with a tetrahydropterin.
    McInnes RR; Kaufman S; Warsh JJ; Van Loon GR; Milstien S; Kapatos G; Soldin S; Walsh P; MacGregor D; Hanley WB
    J Clin Invest; 1984 Feb; 73(2):458-69. PubMed ID: 6142058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atypical (mild) forms of dihydropteridine reductase deficiency: neurochemical evaluation and mutation detection.
    Blau N; Heizmann CW; Sperl W; Korenke GC; Hoffmann GF; Smooker PM; Cotton RG
    Pediatr Res; 1992 Dec; 32(6):726-30. PubMed ID: 1283784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Malignant hyperphenylalaninemia with dihydropteridine reductase deficiency].
    Hyánek J; Zeman J; Niederwieser A; Leeming R; Grimm U; Sahota A; Komárek V; Houst'ková H; Böhm J; Verner P
    Cesk Pediatr; 1986 Nov; 41(11):664-8. PubMed ID: 3791474
    [No Abstract]   [Full Text] [Related]  

  • 18. Folinic acid therapy in treatment of dihydropteridine reductase deficiency.
    Irons M; Levy HL; O'Flynn ME; Stack CV; Langlais PJ; Butler IJ; Milstien S; Kaufman S
    J Pediatr; 1987 Jan; 110(1):61-7. PubMed ID: 2878984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperphenylalaninemia due to dihydropteridine reductase deficiency. Assay of the enzyme in fibroblasts from affected infants, heterozygotes, and in normal amniotic fluid cells.
    Milstien S; Holtzman NA; O'Flynn ME; Thomas GH; Butler IJ; Kaufman S
    J Pediatr; 1976 Nov; 89(5):763-6. PubMed ID: 978323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dihydropteridine reductase deficiency: levodopa's long-term effectiveness without dyskinesia.
    Sedel F; Ribeiro MJ; Remy P; Blau N; Saudubray JM; Agid Y
    Neurology; 2006 Dec; 67(12):2243-5. PubMed ID: 17190955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.